Works matching IS 10781552 AND DT 2023 AND VI 29
Results: 369
Rationalizing prescription via deprescribing in oncology practice.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2007, doi. 10.1177/10781552231207839
- By:
- Publication type:
- Article
Current practices, gaps, and opportunities on the role of clinical pharmacists in cancer pain management: Perspectives from Nepal.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2049, doi. 10.1177/10781552231205025
- By:
- Publication type:
- Article
Polysorbate 80 as a possible allergenic component in cross-allergy to docetaxel and fosaprepitant: A literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1998, doi. 10.1177/10781552231203186
- By:
- Publication type:
- Article
Comment on "Effect of imatinib treatment on renal anemia in chronic myeloid leukemia patients".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Post COVID availability of oncology drugs – Is this the new normal on both sides of the Atlantic?
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2045, doi. 10.1177/10781552231202212
- By:
- Publication type:
- Article
Developing a flowchart to evaluate the use of Closed System Drug-Transfer Devices with monoclonal antibodies: Focus on the clinical trial setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2014, doi. 10.1177/10781552231199412
- By:
- Publication type:
- Article
Carfilzomib-induced life-threatening lung injury in refractory multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2041, doi. 10.1177/10781552231190039
- By:
- Publication type:
- Article
Two patients with fluoropyrimidine overdose successfully managed without uridine triacetate.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2037, doi. 10.1177/10781552231189818
- By:
- Publication type:
- Article
Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2031, doi. 10.1177/10781552231189192
- By:
- Publication type:
- Article
Imatinib mesylate-induced acute hepatotoxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2027, doi. 10.1177/10781552231188307
- By:
- Publication type:
- Article
Delayed presentation of vincristine extravasation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 2023, doi. 10.1177/10781552231187591
- By:
- Publication type:
- Article
Osteonecrosis of the jaw under palbociclib: A case series description.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1990, doi. 10.1177/10781552231165434
- By:
- Publication type:
- Article
CDK4/6 inhibitors in metastatic breast cancer, a comparison of toxicity and efficacy across agents in a real-world dataset.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1825, doi. 10.1177/10781552231163121
- By:
- Publication type:
- Article
Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1982, doi. 10.1177/10781552231162540
- By:
- Publication type:
- Article
Patient-reported outcomes for oral oncolytic therapy: A pilot study utilizing an electronic patient portal in a community cancer center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1974, doi. 10.1177/10781552231162013
- By:
- Publication type:
- Article
Prescribing practices of oncology pharmacists working in ambulatory cancer centers in Alberta.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1965, doi. 10.1177/10781552231162012
- By:
- Publication type:
- Article
Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1957, doi. 10.1177/10781552231161823
- By:
- Publication type:
- Article
A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1951, doi. 10.1177/10781552231161822
- By:
- Publication type:
- Article
Evaluation of chemotherapy infusion and phlebitis among cancer patients: A prospective observational single-center study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1944, doi. 10.1177/10781552231161517
- By:
- Publication type:
- Article
Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1935, doi. 10.1177/10781552231160275
- By:
- Publication type:
- Article
Effect of Imatinib treatment on renal anaemia in chronic myeloid leukemia patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1928, doi. 10.1177/10781552231160113
- By:
- Publication type:
- Article
The impact of a pharmacist-led oral anticancer clinic on medication adherence and laboratory monitoring.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1921, doi. 10.1177/10781552231159870
- By:
- Publication type:
- Article
Evaluation of biliary toxicity in patients with hepatic artery infusion pumps.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1915, doi. 10.1177/10781552231158744
- By:
- Publication type:
- Article
Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1907, doi. 10.1177/10781552231157660
- By:
- Publication type:
- Article
Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1893, doi. 10.1177/10781552231156520
- By:
- Publication type:
- Article
Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1884, doi. 10.1177/10781552231153625
- By:
- Publication type:
- Article
Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1878, doi. 10.1177/10781552231152618
- By:
- Publication type:
- Article
A room of errors simulation to improve pharmacy operators' knowledge of cytotoxic drug production.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1868, doi. 10.1177/10781552231152145
- By:
- Publication type:
- Article
Residual contamination in antineoplastic drug packaging.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1862, doi. 10.1177/10781552231151693
- By:
- Publication type:
- Article
Efficacy of same-day versus next-day administration of pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide: A retrospective multi-site analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1853, doi. 10.1177/10781552221148116
- By:
- Publication type:
- Article
Exploration of current pharmacy practice in cardio-oncology: Experiences & perspectives.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1844, doi. 10.1177/10781552221145667
- By:
- Publication type:
- Article
Implementation of pharmaceutical care service to elderly cancer patients in a tertiary care hospital in South India.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1836, doi. 10.1177/10781552221143065
- By:
- Publication type:
- Article
Developing wipe sampling strategy guidance for assessing environmental contamination of antineoplastic drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1816, doi. 10.1177/10781552221118535
- By:
- Publication type:
- Article
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1806, doi. 10.1177/10781552221117135
- By:
- Publication type:
- Article
Nivolumab for newly and recurrent glioblastoma multiforme treatment: A systematic review and meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1736, doi. 10.1177/10781552231190104
- By:
- Publication type:
- Article
The effect of anamorelin (ONO-7643) on cachexia in cancer patients: Systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1725, doi. 10.1177/10781552231189864
- By:
- Publication type:
- Article
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1797, doi. 10.1177/10781552231186748
- By:
- Publication type:
- Article
Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1793, doi. 10.1177/10781552231185855
- By:
- Publication type:
- Article
Drug extravasation with Enfortumab vedotin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1789, doi. 10.1177/10781552231185505
- By:
- Publication type:
- Article
Acute auto-aggression syndrome following autologous hematopoietic stem cell transplant and lenalidomide for multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1785, doi. 10.1177/10781552231185153
- By:
- Publication type:
- Article
Colonic mucosal diffuse congestion associated with Osimertinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1781, doi. 10.1177/10781552231184182
- By:
- Publication type:
- Article
Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1776, doi. 10.1177/10781552231182936
- By:
- Publication type:
- Article
Gemcitabine-associated digital necrosis in metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1770, doi. 10.1177/10781552231182356
- By:
- Publication type:
- Article
Unusual stroke-like symptoms with oxaliplatin use.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1766, doi. 10.1177/10781552231181525
- By:
- Publication type:
- Article
Anxiety exacerbation in a patient with chronic myeloid leukemia receiving dasatinib and venlafaxine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1762, doi. 10.1177/10781552231181333
- By:
- Publication type:
- Article
Atezolizumab-associated myositis in a patient with unresectable hepatocellular carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1757, doi. 10.1177/10781552231180876
- By:
- Publication type:
- Article
Myocardial bridge in a patient with castration-resistant metastatic prostate cancer treated with enzalutamide.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1754, doi. 10.1177/10781552231180599
- By:
- Publication type:
- Article
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1748, doi. 10.1177/10781552231180598
- By:
- Publication type:
- Article
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1715, doi. 10.1177/10781552221150935
- By:
- Publication type:
- Article
Assessment of patients' knowledge of their treatment with capecitabine at the National Institute of Oncology in Rabat.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1708, doi. 10.1177/10781552221150802
- By:
- Publication type:
- Article